The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Icosapent Ethyl
Icosapent Ethyl Capsules · ICOSAPENT ETHYL 1 g/g · Capsule, Liquid Filled · Oral · Torrent Pharmaceuticals Limited
NDC 13668-0761-12 · 120 g in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for icosapent ethyl (oral solid) in the next 90 days
sole-source market · 1 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA218994
- TE code
- AB
- Approval date
- Dec 20, 2024
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Icosapent Ethyl Capsules (Capsule, Liquid Filled)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Torrent Pharmaceuticals Limited | ICOSAPENT ETHYL 1 g/g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Icosapent Ethyl — NDC 13668-0761-12," retrieved September 3, 2026, https://drugdashboards.com/drug/13668076112.
Free to cite with attribution — see how the data is put together.